It can cause irritation, inflammation, and pain in the rectal area
Persistent vomiting or inability to keep liquids down
This can happen when the body is still adjusting to a new weight and energy balance
However, the proportion of patients experiencing treatment-emergent adverse events on GLP-1RA as add-on to SGL2i was similar to GLP-1RA only and in line with current literature, with most of them being of mild-to-moderate intensity 39,40
You should always inform your GP or prescribing clinician about any supplements you are taking or planning to take whilst on Wegovy
Semaglutide, marketed under the brand names Wegovy (for weight loss) and Ozempic (for type 2 diabetes), currently accounts for 25 per cent of the total Rs 1,579 crore GLP-1 agonist market in India and a potential label expansion gives the company room to tap a new market, insulated from generics and Eli Lillys Mounjaro (tirzepatide), which swept the category last year in both value and volume share